Gene · 4824
Papers3,429
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,429
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances in understanding DNA methylation of prostate cancer. | Front Oncol | 2023 | 37234978 | PubTator, text mining | PubMed |
| Integration analysis of tumor metagenome and peripheral immunity data of diffuse large-B cell lymphoma. | Front Immunol | 2023 | 37234150 | PubTator, text mining | PubMed |
| Morphologic spectrum of the epithelial tumors of the male and female urethra. | Virchows Arch | 2023 | 37233807 | PubTator, text mining | PubMed |
| Functional Epicardial Conduction Disturbances Due to a SCN5A Variant Associated With Brugada Syndrome. | JACC Clin Electrophysiol | 2023 | 37227351 | PubTator, text mining | PubMed |
| Integrating intracellular and extracellular proteomic profiling for in-depth investigations of cellular communication in a model of prostate cancer. | Proteomics | 2023 | 37226375 | PubTator, text mining | PubMed |
| NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease? | Pathology | 2023 | 37225644 | PubTator, text mining | PubMed |
| LncRNA FAS-AS1 upregulated by its genetic variation rs6586163 promotes cell apoptosis in nasopharyngeal carcinoma through regulating mitochondria function and Fas splicing. | Sci Rep | 2023 | 37217794 | PubTator, text mining | PubMed |
| Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review). | Int J Oncol | 2023 | 37203412 | PubTator, text mining | PubMed |
| Medullary carcinoma of the duodenum treated with pembrolizumab: a case report. | J Gastrointest Oncol | 2023 | 37201040 | PubTator, text mining | PubMed |
| Identification of multiple novel susceptibility genes associated with autoimmune thyroid disease. | Front Immunol | 2023 | 37197658 | PubTator, text mining | PubMed |
| Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma. | Sci Rep | 2023 | 37193761 | PubTator, text mining | PubMed |
| Large Cyst of Skene Gland: A Rare Perineum Mass. | Surg J (N Y) | 2023 | 37192958 | PubTator, text mining | PubMed |
| Pharmacological Mechanisms and Clinical Applications of Curcumin: Update. | Aging Dis | 2023 | 37191432 | PubTator, text mining | PubMed |
| The identification of a two-gene prognostic model based on cisplatin resistance-related ceRNA network in small cell lung cancer. | BMC Med Genomics | 2023 | 37189142 | PubTator, text mining | PubMed |
| Prostate Cancer Metastasis to Stomach: A Case Report and Review of Literature. | Curr Oncol | 2023 | 37185408 | PubTator, text mining | PubMed |
| The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features. | Int J Mol Sci | 2023 | 37176106 | PubTator, text mining | PubMed |
| PROTACs in the Management of Prostate Cancer. | Molecules | 2023 | 37175108 | PubTator, text mining | PubMed |
| Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells. | Stem Cell Reports | 2023 | 37172587 | PubTator, text mining | PubMed |
| The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer. | Front Cell Dev Biol | 2023 | 37152294 | PubTator, text mining | PubMed |
| Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment. | J Immunother Cancer | 2023 | 37147019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4824/papers?page=18